Literature DB >> 23787054

Human colonic mucus is a reservoir for antimicrobial peptides.

Lena Antoni1, Sabine Nuding, Dagmar Weller, Michael Gersemann, German Ott, Jan Wehkamp, Eduard F Stange.   

Abstract

BACKGROUND AND AIMS: To prevent bacterial adherence and translocation, the colonic mucosa is covered by a protecting mucus layer and the epithelium synthesizes antimicrobial peptides. The present qualitative study investigated the contents and interaction of these peptides in and with rectal mucus.
METHODS: Rectal mucus extracts were analyzed for antimicrobial activity and screened with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, Dot blot and immunohistochemistry for antimicrobial peptides. In addition, binding of AMPs to mucins was investigated by Western blot and enzyme-linked lectin assays.
RESULTS: In functional tests the mucus layer exhibited a strong antimicrobial activity. We detected 11 antimicrobial peptides in mucus extracts from healthy persons including the defensins HBD-1 and -3, the cathelicidin LL-37, ubiquitin, lysozyme, histones, high mobility group nucleosome-binding domain-containing protein 2, ubiquicidin and other ribosomal proteins. AMPs were bound by mucins but this was demonstrated to be reversible and inhibition of antibacterial activity was limited.
CONCLUSION: These findings indicate that epithelial antimicrobial peptides are retained in the intestinal mucus layer without losing their efficacy. Thus, the mucus layer and its composition provide an attractive drug target to restore antimicrobial barrier function in intestinal diseases.
Copyright © 2013 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AMP; Antimicrobial peptides;; ELLA; HMGN2; Inflammatory bowel disease;; Large intestine; MALDI-TOF-MS; Mucus;; RP-HPLC; antimicrobial peptide; enzyme-linked lectin assay; high mobility group nucleosome-binding domain-containing protein 2; matrix-assisted laser desorption/ionization time-of-flight mass spectrometry; reversed-phase high-performance liquid chromatography

Mesh:

Substances:

Year:  2013        PMID: 23787054     DOI: 10.1016/j.crohns.2013.05.006

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  38 in total

1.  Mucosal Barrier Depletion and Loss of Bacterial Diversity are Primary Abnormalities in Paediatric Ulcerative Colitis.

Authors:  Misagh Alipour; Deenaz Zaidi; Rosica Valcheva; Juan Jovel; Inés Martínez; Consolato Sergi; Jens Walter; Andrew L Mason; Gane Ka-Shu Wong; Levinus A Dieleman; Matthew W Carroll; Hien Q Huynh; Eytan Wine
Journal:  J Crohns Colitis       Date:  2015-12-09       Impact factor: 9.071

Review 2.  Physiologic hypoxia and oxygen homeostasis in the healthy intestine. A Review in the Theme: Cellular Responses to Hypoxia.

Authors:  Leon Zheng; Caleb J Kelly; Sean P Colgan
Journal:  Am J Physiol Cell Physiol       Date:  2015-07-15       Impact factor: 4.249

Review 3.  Oxygen metabolism and innate immune responses in the gut.

Authors:  Sean P Colgan; Eric L Campbell
Journal:  J Appl Physiol (1985)       Date:  2017-07-13

4.  Antimicrobial peptides and the enteric mucus layer act in concert to protect the intestinal mucosa.

Authors:  Aline Dupont; Lena Heinbockel; Klaus Brandenburg; Mathias W Hornef
Journal:  Gut Microbes       Date:  2014

Review 5.  The intestinal microbiota: its role in health and disease.

Authors:  Luc Biedermann; Gerhard Rogler
Journal:  Eur J Pediatr       Date:  2015-01-07       Impact factor: 3.183

6.  MUC2 Mucin and Butyrate Contribute to the Synthesis of the Antimicrobial Peptide Cathelicidin in Response to Entamoeba histolytica- and Dextran Sodium Sulfate-Induced Colitis.

Authors:  Eduardo R Cobo; Vanessa Kissoon-Singh; France Moreau; Ravi Holani; Kris Chadee
Journal:  Infect Immun       Date:  2017-02-23       Impact factor: 3.441

Review 7.  Oxygen metabolism and barrier regulation in the intestinal mucosa.

Authors:  Louise E Glover; J Scott Lee; Sean P Colgan
Journal:  J Clin Invest       Date:  2016-08-08       Impact factor: 14.808

Review 8.  Inflammatory Bowel Disease.

Authors:  Jan Wehkamp; Martin Götz; Klaus Herrlinger; Wolfgang Steurer; Eduard F Stange
Journal:  Dtsch Arztebl Int       Date:  2016-02-05       Impact factor: 5.594

Review 9.  Immune-epithelial crosstalk at the intestinal surface.

Authors:  Nadine Wittkopf; Markus F Neurath; Christoph Becker
Journal:  J Gastroenterol       Date:  2014-01-28       Impact factor: 7.527

Review 10.  Intestinal barrier in inflammatory bowel disease.

Authors:  Lena Antoni; Sabine Nuding; Jan Wehkamp; Eduard F Stange
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.